首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
coated coronary artery stent implantation 相关文献:
Clinical Outcomes of Drug-Coated Balloons in Coronary Artery Disease Unsuitable for Drug-Eluting Stent Implantation.
PMID:
Two-year clinical outcome after abciximab-coated stent implantation in patients with coronary artery disease.
PMID:
Randomized comparative study of diamond-like carbon coated stainless steel stent versus uncoated stent implantation in patients with coronary artery disease.
PMID:
Drug-Coated Balloons in the Management of Coronary Artery Disease.
Korjian S, McCarthy KJ, Larnard EA, Cutlip DE, McEntegart MB, Kirtane AJ, Yeh RW.
Circ Cardiovasc Interv. 2024 May;17(5):e013302. doi: 10.1161/CIRCINTERVENTIONS.123.013302. Epub 2024 May 21.
PMID:38771909
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
Giacoppo D, Alvarez-Covarrubias HA, Koch T, Cassese S, Xhepa E, Kessler T, Wiebe J, Joner M, Hochholzer W, Laugwitz KL, Schunkert H, Kastrati A, Kufner S.
Eur Heart J. 2023 Apr 17;44(15):1343-1357. doi: 10.1093/eurheartj/ehad026.
PMID:36807512
Clinical Outcomes of Drug-Coated Balloons in Coronary Artery Disease Unsuitable for Drug-Eluting Stent Implantation.
Iijima R, Kougame N, Hara H, Moroi M, Nakamura M.
Circ J. 2018 Jul 25;82(8):2025-2031. doi: 10.1253/circj.CJ-18-0121. Epub 2018 Jun 12.
PMID:29899199
Coronary stent failure: role of a blended approach with drug-coated balloons for complex lesions.
Cortese B, Sanchez-Jimenez E, Lazar L.
Minerva Cardiol Angiol. 2024 Jun;72(3):266-280. doi: 10.23736/S2724-5683.22.06172-5. Epub 2023 Mar 20.
PMID:36939731
Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study.
Rusinaru D, Vrolix M, Verheye S, Chowdhary S, Schoors D, Di Mario C, Desmet W, Donohoe DJ, Ormiston JA, Knape C, Bezerra H, Lansky A, Wijns W; DESSOLVE II Investigators.
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1141-50. doi: 10.1002/ccd.25610. Epub 2015 Sep 22.
PMID:25044635
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
Greco A, Sciahbasi A, Abizaid A, Mehran R, Rigattieri S, de la Torre Hernandez JM, Alfonso F, Cortese B.
Catheter Cardiovasc Interv. 2022 Oct;100(4):544-552. doi: 10.1002/ccd.30358. Epub 2022 Sep 2.
PMID:36054266
Expanding indications for drug-coated balloons in coronary artery disease.
Greco A, Di Leo G, Spagnolo M, Giacoppo D, Capodanno D.
Expert Rev Med Devices. 2025 Apr;22(4):321-338. doi: 10.1080/17434440.2025.2474179. Epub 2025 Mar 7.
PMID:40016088
Coronary artery stenting.
Ashby DT, Dangas G, Mehran R, Leon MB.
Catheter Cardiovasc Interv. 2002 May;56(1):83-102. doi: 10.1002/ccd.10209.
PMID:11979540
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes.
Gitto M, Leone PP, Gioia F, Chiarito M, Latini A, Tartaglia F, Kilic ID, Rossi ML, Regazzoli D, Gasparini G, Cozzi O, Sticchi A, Condorelli G, Reimers B, Stefanini G, Mangieri A, Colombo A.
Am J Cardiol. 2025 Mar 15;239:28-35. doi: 10.1016/j.amjcard.2024.12.008. Epub 2024 Dec 10.
PMID:39667516
Vascular healing in high-bleeding-risk patients at 3-month after everolimus-eluting stent versus biolimus A9-coated stent implantation: insights from analysis of optical coherence tomography and coronary angioscopy.
Koiwaya H, Nishihira K, Kadooka K, Kuriyama N, Shibata Y.
Cardiovasc Interv Ther. 2023 Jan;38(1):64-74. doi: 10.1007/s12928-022-00877-9. Epub 2022 Aug 2.
PMID:35918588
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3